九典制药涨2.06%，成交额1.27亿元，主力资金净流入776.50万元

Core Viewpoint - JiuDian Pharmaceutical's stock has shown a slight increase of 2.06% on November 14, with a current price of 17.30 CNY per share and a total market capitalization of 8.654 billion CNY. The company has experienced a year-to-date stock price decline of 1.93% but has seen a recent uptick in the last five trading days, rising by 4.85% [1]. Group 1: Financial Performance - For the period from January to September 2025, JiuDian Pharmaceutical reported a revenue of 2.268 billion CNY, reflecting a year-on-year growth of 5.69%. However, the net profit attributable to shareholders decreased by 9.64% to 406 million CNY [2]. - The company has distributed a total of 450 million CNY in dividends since its A-share listing, with 346 million CNY distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for JiuDian Pharmaceutical decreased by 10.37% to 34,700, while the average number of tradable shares per shareholder increased by 11.56% to 10,645 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 4.9433 million shares, a decrease of 2.1171 million shares from the previous period. New shareholders include Guotai Double Benefit Bond A and Anxin Medical Health Stock A [3].